|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
The symptom such as pneumonia, fever, breathing difficulty, and lung infection are commonly shown by coronavirus belongs to a family of viruses. The World Health Organization (WHO) on 11th February 2020 announced this virus official name as COVID-19 which full form is Corona Virus Infectious Disease and 19 indicates that it originated in 2019.Despite the efforts of the entire world to grasp COVID-19, many issues remain unclear. The Director-General of WHO declared the outbreak of COVID-19 as a Public Health Emergency of International Concern on 30 January 2020. Rapid diagnostics play a very important role in disease and outbreak management. The fast and accurate diagnosis of a speciï¬c infection enables prompt and accurate public health surveillance, prevention, and control measures. In conclusion, it remains a challenging task to fight the 2019-nCoV of unknown origin and biological features and to manage an outbreak of COVID-19. Rapid diagnostics, vaccines, and therapeutics are key pharmaceutical interventions to limit the transmission of respiratory infectious diseases.